Nature's Sunshine Products, Inc. (NATR)
| Market Cap | 222.41M -14.2% |
| Revenue (ttm) | 492.02M +6.8% |
| Net Income | 18.10M +28.3% |
| EPS | 1.00 +33.5% |
| Shares Out | 17.60M |
| PE Ratio | 12.64 |
| Forward PE | 11.76 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 87,420 |
| Open | 12.00 |
| Previous Close | 12.61 |
| Day's Range | 12.00 - 13.04 |
| 52-Week Range | 12.00 - 28.14 |
| Beta | 0.81 |
| Analysts | Strong Buy |
| Price Target | 30.50 (+141.3%) |
| Est. Earnings | Nov 5, 2026 |
About NATR
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate in... [Read more]
Financial Performance
In 2025, NATR's revenue was $480.14 million, an increase of 5.67% compared to the previous year's $454.36 million. Earnings were $19.52 million, an increase of 153.65%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for NATR stock is "Strong Buy." The 12-month stock price target is $30.5, which is an increase of 141.30% from the latest price.
News
Nature's Sunshine Products Transcript: Canaccord Genuity's 46th Annual Growth Conference
The company is leveraging its global presence, strong financials, and experienced leadership to pursue aggressive growth through geographic expansion, digital channels, product innovation, and disciplined M&A. Plans include doubling sales, expanding in new and existing markets, and launching a new marketing campaign.
Nature’s Sunshine price target lowered to $25 from $33 at DA Davidson
DA Davidson lowered the firm’s price target on Nature’s Sunshine (NATR) to $25 from $33 and keeps a Buy rating on the shares. The company’s Q2 missed due to an…
Nature’s Sunshine appoints Ruth Perkins as CFO
Nature’s Sunshine (NATR) announced the appointment of Ruth Perkins as executive VP and CFO, effective September 1. Perkins will serve as a member of the company’s growth leadership team and…
Nature's Sunshine Products Earnings Call Transcript: Q2 2026
Q2 net sales reached a record $117 million, up 2% year-over-year, with strong digital and regional growth, though China sales declined 20%. Gross margin hit 73.7%, and 2026 guidance was lowered due to FX and China. Strategic investments and leadership changes support long-term growth.
Nature's Sunshine Products Earnings release: Q2 2026
Nature's Sunshine Products released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Nature's Sunshine Products Slides: Q2 2026
Nature's Sunshine Products has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Nature's Sunshine Products Quarterly report: Q2 2026
Nature's Sunshine Products has published its Q2 2026 quarterly earnings report on August 6, 2026.
Nature's Sunshine Reports Second Quarter 2026 Results
LEHI, Utah, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine"), a global leader in manufacturing and marketing high-quality herbal and nutritional ...
Nature's Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer
LEHI, Utah, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, today ann...
Nature's Sunshine Appoints Janine Weber as Executive Vice President and President, North America
LEHI, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, today ann...
Nature’s Sunshine price target lowered to $36 from $37 at Canaccord
Canaccord lowered the firm’s price target on Nature’s Sunshine (NATR) to $36 from $37 and keeps a Buy rating on the shares. The firm updated its model ahead of Q2…
Nature's Sunshine Sets Second Quarter 2026 Conference Call for Thursday, August 6, 2026, at 5:00 p.m. ET
LEHI, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality he...
Nature's Sunshine Products Slides: Investor presentation
Nature's Sunshine Products has posted slides in relation to its latest quarterly earnings report, which was published on June 9, 2026.
Nature’s Sunshine price target raised to $37 from $33 at Canaccord
Canaccord raised the firm’s price target on Nature’s Sunshine (NATR) to $37 from $33 and keeps a Buy rating on the shares. The firm said they reported better than expected…
Nature's Sunshine Products Earnings Call Transcript: Q1 2026
Q1 2026 delivered 9% sales and 33% EBITDA growth, led by digital expansion and strong regional performance. Guidance for 2026 is reaffirmed, with investments in technology and product innovation expected to drive sustainable growth.
Nature's Sunshine Products Earnings release: Q1 2026
Nature's Sunshine Products released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Nature's Sunshine Products Slides: Q1 2026
Nature's Sunshine Products has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Nature's Sunshine Products Quarterly report: Q1 2026
Nature's Sunshine Products has published its Q1 2026 quarterly earnings report on May 7, 2026.
Nature's Sunshine Reports Strong First Quarter 2026 Results
Net Sales up 9% to $122.9 million, GAAP EPS up 16% to $0.29Adjusted EBITDA up 33% to $14.6 million LEHI, Utah, May 07, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature...
Nature’s Sunshine appoints John Hnanicek as chief technology officer
Nature’s Sunshine (NATR) announced that John Hnanicek has been appointed chief technology officer, effective May 4. Hnanicek most recently served as chief digital innovation officer at Melaleuca, wher...
Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer
Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strategy Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strat...
Nature's Sunshine Sets First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 5:00 p.m. ET
LEHI, Utah, April 23, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality h...
Nature's Sunshine Products Proxy statement: Proxy filing
Nature's Sunshine Products filed a proxy statement on April 20, 2026, providing details for shareholder voting and corporate governance matters.
Nature's Sunshine Products Slides: Investor presentation
Nature's Sunshine Products has posted slides in relation to its latest quarterly earnings report, which was published on April 9, 2026.
Nature's Sunshine Products Proxy statement: Proxy filing
Nature's Sunshine Products filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.